Loading…
Big Four accounting firm assigns midpoint equity value of approximately US$19 million.
NewGenIvf Group Ltd announced on 2026-07-06 NewGenIvf Group Ltd announced a valuation of its planned UAE-based cell sorting and cytometry leasing business by a Big Four global accounting firm, assigning a midpoint equity value of approximately US$19 million.
The announcement cited US$19 million, US$17.9 million, ~US$270 million, ~US$444 million, CAGR ~8.5%, and 74.4 million.
NewGenIvf Group Ltd has a free float of 562,123 shares and 10,259,764 shares outstanding.
This summary was generated by AI from public sources and may contain errors. Not financial advice. Trade at your own risk.